ACE inhibitor trandolapril effectiveness in arterial hypertension
About the Authors
K. I. TebloevRussian Federation
K. A. Memetov
Russian Federation
T. N. Minnikova
Russian Federation
K. A. Fomina
Russian Federation
M. P. Obukhova
Russian Federation
I. S. Golyshev
Russian Federation
References
1. Bouvier O'Yvoire M., Caplain H., Stepniewski J. P. Comparison of plasma ACE activity after discontinuation of repeated doses of trandolapril or enalapril [abstract].//Am. J. Hypertension. 1994. N 7 (Pt2). P. 35 A.
2. Con Due L., Brunner H. Trandolapril in hypertension: overview of a new angiotensin-converting enzyme inhibitor.//Am. J. Cardiol. 1992. N 70 P. 27D-34D.
3. Aranda P., Aranda F.J., Frutos M., et al. Amlodipine versus trandolapril in type 2 diabetic essential hypertensives: a long-term comparison study [abstract].//Am. J. Hypertension. 1996. N 9 (Pt 2). P. 143 A.
4. Schneider M., Lerch M., Papari M. et al. Metabolic neutrality of combined verapamil-trandolapril treatment in contrast to beta-blocker -low dose chlortalidone treatment in hypestensive type 2 diabetes. // J. Hypertension. 1996. N 14. P. 669-677.
5. Рекомендации по диагностике и лечению артериальной гипертензии. Всероссийское научное общество кардиологов (ВНОК), секция артериальной гипертензии.//Consilium medicum. Приложение «Артериальная гипертония». 2001. С. 3-11.
6. Рекомендации 1999. по лечению артериальной гипертензии международного общества по вопросам артериальной гипертензии и всемирной организации здравоохранения.//Артериальная гипертензия. 1999. Т. 5, № 2. С. 10.
7. Richer С., Mulder P., Fornes P. et al. Long-term treatment with trandolapril opposes cardiac remodeling and myocardial infarction in rats. // J. Cardiovasc. Pharmacol. 1992. N 20. P.147-156.
8. Gosse P., Roudaut R., Herrero G., Dallocchino M. Beta-blockers vs. angiotensin-converting enzyme inhibitors in hypertension: effects on left ventricular hypertrophy.//J.Cardiovasc. Pharmacol. 1990. V. 16, Suppl. 5. P. 145-150.
9. Cohen H., Brunner H. Pharmacologic profile of trandolapril, anew angiotensinconverting enzyme inhibitir. // Am. Heart. J. 1993. N 125. P. 1525-1531.
10. Brown N., Badel M., Benzoni F. et al. Angiotensin-converting enzyme inhibitor, antihypertensive activity and hemodynamic profile of trandolapril (RU 44570).//Eur. J. Pharmacol. 1988. N 148. P. 79-91.
11. Bauduceau B., Vaur L., Rezvani Y., et al. Action of trandolapril on the blood glucose balance and microalbuminuria in hypertensive diabetics [in French].//Ann. Cardiol. Angeiol. 1994. N 43. P.84-88
12. Bakris G.L., Gaxiola E., Messerli F.H. et al. Clinical outcomes in the diabetes cohort of the INternational VErapamil SR-Trandolapril study. // Hypertension. 2004. V. 44, N 5. P. 637-642.
Review
For citations:
Tebloev K.I., Memetov K.A., Minnikova T.N., Fomina K.A., Obukhova M.P., Golyshev I.S. ACE inhibitor trandolapril effectiveness in arterial hypertension. Russian Journal of Cardiology. 2008;(2):35-39. (In Russ.)